Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007 - PubMed (original) (raw)
. 2007 Nov;13(11):1268-85.
doi: 10.1016/j.bbmt.2007.08.005.
Claudio Anasetti, Edward Stadtmauer, Joseph Antin, John Wingard, Stephanie Lee, John Levine, Kirk Schultz, Frederick Appelbaum, Robert Negrin, Sergio Giralt, Christopher Bredeson, Helen Heslop, Mary Horowitz
Affiliations
- PMID: 17950914
- DOI: 10.1016/j.bbmt.2007.08.005
Free article
Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007
James L M Ferrara et al. Biol Blood Marrow Transplant. 2007 Nov.
Free article
Abstract
Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field. This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years.
Similar articles
- Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.
Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM. Heslop HE, et al. Transplant Cell Ther. 2021 Nov;27(11):885-907. doi: 10.1016/j.jtct.2021.08.016. Epub 2021 Aug 27. Transplant Cell Ther. 2021. PMID: 34461278 Free PMC article. Review. - Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007.
Ferrara JL. Ferrara JL. Biol Blood Marrow Transplant. 2014 Feb;20(2):149-53. doi: 10.1016/j.bbmt.2013.11.006. Epub 2013 Nov 12. Biol Blood Marrow Transplant. 2014. PMID: 24239651 Free PMC article. - Use of alternative donors for allogeneic stem cell transplantation.
Anasetti C. Anasetti C. Hematology Am Soc Hematol Educ Program. 2015;2015:220-4. doi: 10.1182/asheducation-2015.1.220. Hematology Am Soc Hematol Educ Program. 2015. PMID: 26637725 Review. - Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?
Adhikari J, Sharma P, Bhatt VR. Adhikari J, et al. Future Oncol. 2016 Aug;12(15):1823-32. doi: 10.2217/fon-2016-0106. Epub 2016 May 11. Future Oncol. 2016. PMID: 27168462 Review. - Should all unrelated donors for transplantation be matched?
Weisdorf D. Weisdorf D. Best Pract Res Clin Haematol. 2008 Mar;21(1):79-83. doi: 10.1016/j.beha.2007.11.011. Best Pract Res Clin Haematol. 2008. PMID: 18342815 Free PMC article.
Cited by
- Comparing the risk of severe oral mucositis associated with methotrexate as graft-versus host-disease prophylaxis to other immunosuppressive prophylactic agents in hematopoietic cell transplantation: a systematic review and meta-analysis.
Al-Jamaei AAH, Epstein JB, de Visscher JGAM, Spielberger RT, Nakamura R, Raber-Durlacher JE. Al-Jamaei AAH, et al. Support Care Cancer. 2024 Jul 17;32(8):519. doi: 10.1007/s00520-024-08722-w. Support Care Cancer. 2024. PMID: 39017899 Free PMC article. - Tacrolimus/methotrexate vs tacrolimus/reduced-dose methotrexate/mycophenolate for graft-versus-host disease prevention.
Hamilton BK, Rybicki LA, Li H, Lucas T, Corrigan D, Kalaycio M, Sobecks R, Hanna R, Rotz SJ, Dean RM, Gerds AT, Jagadeesh D, Brunstein C, Sauter CS, Copelan EA, Majhail NS. Hamilton BK, et al. Blood Adv. 2023 Aug 22;7(16):4505-4513. doi: 10.1182/bloodadvances.2023010310. Blood Adv. 2023. PMID: 37352262 Free PMC article. Clinical Trial. - Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice.
Hamilton BK, Cutler C, Divine C, Juckett M, LeMaistre C, Stewart S, Wilder J, Horowitz M, Khera N, Burns LJ. Hamilton BK, et al. Transplant Cell Ther. 2022 Aug;28(8):419-425. doi: 10.1016/j.jtct.2022.05.002. Epub 2022 May 9. Transplant Cell Ther. 2022. PMID: 35550441 Free PMC article. - Updates in chronic graft-versus-host disease.
Hamilton BK. Hamilton BK. Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):648-654. doi: 10.1182/hematology.2021000301. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889364 Free PMC article. Review. - Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year.
Heslop HE, Stadtmauer EA, Levine JE, Ballen KK, Chen YB, DeZern AE, Eapen M, Hamadani M, Hamilton BK, Hari P, Jones RJ, Logan BR, Kean LS, Leifer ES, Locke FL, Maziarz RT, Nemecek ER, Pasquini M, Phelan R, Riches ML, Shaw BE, Walters MC, Foley A, Devine SM, Horowitz MM. Heslop HE, et al. Transplant Cell Ther. 2021 Nov;27(11):885-907. doi: 10.1016/j.jtct.2021.08.016. Epub 2021 Aug 27. Transplant Cell Ther. 2021. PMID: 34461278 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
- U10 HL069294/HL/NHLBI NIH HHS/United States
- U10 HL069254/HL/NHLBI NIH HHS/United States
- U24 CA076518/CA/NCI NIH HHS/United States
- U10 HL069301/HL/NHLBI NIH HHS/United States
- U10 HL069330/HL/NHLBI NIH HHS/United States
- U10 HL069249/HL/NHLBI NIH HHS/United States
- 1 R13 HL88882-01/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical